In line with current literature data, TP53 was found to be mutated with significantly higher frequency among CRC cases than in adenomas, leading to the inactivation of this gene and contributing to the transition step from adenoma to carcinoma [12,48]. The gene discussed is TP53; the disease is carcinoma.